Two Sigma Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,500
Closed -$697K 3226
2023
Q3
$697K Buy
23,500
+14,900
+173% +$524K 0.01% 1280
2023
Q2
$308K Sell
8,600
-900
-9% -$25.8K ﹤0.01% 1849
2023
Q1
$223K Buy
+9,500
New +$271K ﹤0.01% 1987
2022
Q3
Sell
-11,300
Closed -$456K 2773
2022
Q2
$456K Buy
+11,300
New +$560K 0.02% 980
2021
Q4
Sell
-2,400
Closed -$300K 1728
2021
Q3
$300K Buy
2,400
+600
+33% +$71.3K 0.01% 1002
2021
Q2
$224K Buy
+1,800
New +$242K 0.01% 1208
2020
Q4
Sell
-2,400
Closed -$268K 1766
2020
Q3
$268K Buy
+2,400
New +$220K 0.01% 931
2020
Q1
Sell
-12,100
Closed -$945K 1702
2019
Q4
$945K Buy
12,100
+2,800
+30% +$202K 0.01% 1074
2019
Q3
$594K Buy
+9,300
New +$819K 0.01% 1106

Other funds holding GH

Two Sigma Securities's GH Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Guardant Health (GH) in Q2 2026: 6,432 shares worth $965K. The stake represents 0.08% of the portfolio and ranks #305 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in GH as recently as Q3 2024.

Two Sigma Securities first reported a position in GH in Q1 2021 and has held it in 9 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Two Sigma Securities held 6,432 shares of Guardant Health worth $965K as of Q2 2026.
  • Guardant Health was a new Two Sigma Securities position in Q2 2026.
  • Guardant Health made up 0.08% of Two Sigma Securities's portfolio in Q2 2026, its #305 holding.
  • Two Sigma Securities first reported a position in Guardant Health in Q1 2021 and has held it in 9 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.